ZYLAPINE olanzapine 2.5 mg uncoated tablet blister pack

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

olanzapine, Quantity: 2.5 mg

Tilgjengelig fra:

Arrotex Pharmaceuticals Pty Ltd

Legemiddelform:

Tablet, uncoated

Sammensetning:

Excipient Ingredients: crospovidone; lactose monohydrate; magnesium stearate; hyprolose

Administreringsrute:

Oral

Enheter i pakken:

28

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

ZYLAPINE is indicated for the treatment of schizophrenia and related psychoses. ,ZYLAPINE alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. ,ZYLAPINE is indicated for preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.

Produkt oppsummering:

Visual Identification: Yellow coloured, circular, biconvex uncoated tablets, debossed with "C" on one side and "45" on the other side; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Autorisasjon status:

Licence status A

Autorisasjon dato:

2017-11-03